Area of research
Virology · Immunology
Research interest
Research interests include HIV Research and Treatment, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and SARS-CoV-2 and COVID-19 Research.
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.
Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection.
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates
Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
Immune checkpoint modulation enhances HIV-1 antibody induction
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection
Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site
Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved
Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1
Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion